Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors

Hanwen Wang, Aleksander S. Popel, Mohammad Jafarnejad et al.|Frontiers in Bioengineering and Biotechnology|2020

Cited by 53